Follow this innovation
[ via 
] [?]
The Integrin Activation Interface
University of California System: University of California, San Diego Technology Transfer Office
posted on 07/01/2009
Integrins are found throughout the animal kingdom where they play important roles in cell adhesion, migration, proliferation, and survival. In humans, integrins play critical roles in development. Aberrant activation is implicated in several disease states, including cancer and heart disease. Thus, drugs aimed at disrupting this specific interaction could lead to therapies for these conditions.
Advantages
- Can be used with high specificity to modulate the talin-integrin beta-sub3 interaction without the side effects that may occur with presently available therapeutic agents and methods.
- Offers a new screening method to detect agents that block integrin beta-sub3 activation, as well as a method for screening alterations in talin function.
- Available as DNA constructs and vectors.
Detailed Description
Researchers at UC San Diego have elucidated a novel molecular interface between two proteins, talin and the membrane proximal portion of the beta-sub3 integrin domain. Specifically, the research team has identified and validated a specific structural target that was previously unknown and could aid in the design of therapeutics to block integrin activation. This discovery may enable the engineering of cells with defects in the activation of multiple classes of integrins and offers a new target for therapeutic intervention to treat diseases and conditions such as inflammation, autoimmune diseases, heart disease (including myocardial infarction), and cancer.
File Number: 19150
Disease: Autoimmune and Inflammation
Other Information:
Intellectual Property Info
This invention is available for licensing. See international patent application, published 24-July-2008 (2008/051016).
| Patent Number(s): | 2010/0210525 |
|---|---|
| Copyright: | ©2009-2011, The Regents of the University of California |
This innovation currently is not available for online licensing. Please contact University of California, San Diego Technology Transfer Office at University of California System: University of California, San Diego Technology Transfer Office for more information.
request more info
Case Manager:
 |
University of California, San Diego Technology Transfer Office
Innovations (747) |
|---|
ProfileFind more innovations
